The table below shows Jazz Pharmaceuticals plc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$4.27B
$4.07B
$3.83B
$3.66B
$3.09B
$2.36B
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
$1.81B
JAZZ annual revenue (10-K history)
Jazz Pharmaceuticals plc reported annual revenue of $4.27B for fiscal year 2025. That is up 4.9% from $4.07B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.49B (FY 2016) to $4.27B. Figures come from the company's audited annual reports as filed with the SEC.
